Please assess the completion status of the following clinical trial:

Trial Title: Single and Multiple Ascending Dose Study of AMG 171 in Subjects With Obesity

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SEQUENTIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria~* Males and females with ages between 18 and 65 years old, inclusive~* Except for obesity, otherwise healthy~* Body mass index (BMI) greater than or equal to 30.0 kg/m2 and less than or equal to 40.0 kg/m2 at screening~* Other Inclusion criteria may apply~Exclusion Criteria:~* Currently receiving treatment in another investigational device or drug study~* Women of childbearing potential~* History or evidence of a clinically significant disorder, condition or disease that would pose a risk to subject safety or interfere with the study evaluation, procedures or completion~* Other Exclusion criteria may apply

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Part A (Type: EXPERIMENTAL): AMG 171 or placebo, 2 SAD cohorts
- Part B (Type: EXPERIMENTAL): AMG 171 or placebo, 1 MAD cohort
- Part C (Type: EXPERIMENTAL): AMG 171 or placebo, 3 titration cohorts

Based on this trial design, predict the completion outcome and termination type (if applicable).